Zoetis Inc. (ZTS): Price and Financial Metrics


Zoetis Inc. (ZTS): $174.61

5.44 (+3.22%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ZTS POWR Grades


  • ZTS scores best on the Quality dimension, with a Quality rank ahead of 96.35% of US stocks.
  • ZTS's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • ZTS's current lowest rank is in the Momentum metric (where it is better than 14.48% of US stocks).

ZTS Stock Summary

  • ZTS has a market capitalization of $90,750,503,122 -- more than approximately 97.07% of US stocks.
  • With a one year PEG ratio of 204.33, Zoetis Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 87.91% of US stocks.
  • ZTS's price/sales ratio is 11.67; that's higher than the P/S ratio of 87.5% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Zoetis Inc, a group of peers worth examining would be MMM, SYK, GE, BSX, and ABB.
  • Visit ZTS's SEC page to see the company's official filings. To visit the company's web site, go to www.zoetis.com.

ZTS Valuation Summary

  • In comparison to the median Healthcare stock, ZTS's EV/EBIT ratio is 33.45% higher, now standing at 39.1.
  • ZTS's price/sales ratio has moved up 9.4 over the prior 104 months.
  • Over the past 104 months, ZTS's price/earnings ratio has gone down 12.5.

Below are key valuation metrics over time for ZTS.

Stock Date P/S P/B P/E EV/EBIT
ZTS 2021-08-31 13.1 22.3 50.8 39.1
ZTS 2021-08-30 13.2 22.4 51.1 39.3
ZTS 2021-08-27 13.0 22.2 50.6 38.9
ZTS 2021-08-26 13.0 22.2 50.7 39.0
ZTS 2021-08-25 13.1 22.3 50.8 39.0
ZTS 2021-08-24 13.1 22.3 50.9 39.1

ZTS Growth Metrics

    The 5 year net cashflow from operations growth rate now stands at 176.95%.
  • The year over year net cashflow from operations growth rate now stands at 16.76%.
  • Its 5 year revenue growth rate is now at 31.38%.
ZTS's revenue has moved up $2,652,000,000 over the prior 52 months.

The table below shows ZTS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 7,776 2,213 2,037
2021-09-30 7,616 2,252 1,982
2021-06-30 7,412 2,161 1,909
2021-03-31 7,012 2,118 1,774
2020-12-31 6,675 2,126 1,638
2020-09-30 6,542 1,990 1,663

ZTS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ZTS has a Quality Grade of A, ranking ahead of 95.14% of graded US stocks.
  • ZTS's asset turnover comes in at 0.552 -- ranking 69th of 682 Pharmaceutical Products stocks.
  • UTHR, ENDP, and MYGN are the stocks whose asset turnover ratios are most correlated with ZTS.

The table below shows ZTS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.552 0.697 0.236
2021-06-30 0.537 0.695 0.233
2021-03-31 0.518 0.694 0.219
2020-12-31 0.514 0.692 0.206
2020-09-30 0.525 0.696 0.212
2020-06-30 0.535 0.697 0.207

ZTS Price Target

For more insight on analysts targets of ZTS, see our ZTS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $185.00 Average Broker Recommendation 1.34 (Strong Buy)

ZTS Stock Price Chart Interactive Chart >

Price chart for ZTS

ZTS Price/Volume Stats

Current price $174.61 52-week high $249.27
Prev. close $169.17 52-week low $154.18
Day low $171.39 Volume 3,255,000
Day high $174.68 Avg. volume 2,407,073
50-day MA $169.91 Dividend yield 0.74%
200-day MA $197.63 Market Cap 82.18B

Zoetis Inc. (ZTS) Company Bio


Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets the products in approximately 45 countries, and sells the products in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. (Source:Wikipedia)


ZTS Latest News Stream


Event/Time News Detail
Loading, please wait...

ZTS Latest Social Stream


Loading social stream, please wait...

View Full ZTS Social Stream

Latest ZTS News From Around the Web

Below are the latest news stories about Zoetis Inc that investors may wish to consider to help them evaluate ZTS as an investment opportunity.

3 Beaten-Down Growth Stocks With More Than 50% Upside Potential

The key to picking growth stocks right now is to look for companies whose earnings momentum and growth can withstand any market conditions.

Jaimini Desai on InvestorPlace | February 25, 2022

Zoetis to Participate in the Bank of America Securities 2022 Animal Health Summit

PARSIPPANY, N.J., February 22, 2022--Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2022 Animal Health Summit on Thursday, Feb. 24, 2022.

Yahoo | February 22, 2022

Analysts Are Bullish on These Healthcare Stocks: Zoetis (ZTS), SAGE Therapeutics (SAGE)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zoetis (ZTS – Research Report), SAGE Therapeutics (SAGE – Research Report) and Crispr Therapeutics AG (CRSP – Research Report) with bullish sentiments. Zoetis (ZTS) In a report released yesterday, David Steinberg from Jefferies maintained a Buy rating on Zoetis, with a price target of $235.00. The company's shares closed last Tuesday at $197.76. According to TipRanks.

Christine Brown on TipRanks | February 16, 2022

Company News for Feb 16, 2022

Companies In The News Are: MAR, ZTS, TRP, ANET.

Yahoo | February 16, 2022

4 Top Stock Trades for Wednesday: NVDA, SPCE, ABNB, ZTS

Nvidia, Virgin Galactic, Airbnb and Zoetis were our top stock trades for Wednesday.

Bret Kenwell on InvestorPlace | February 15, 2022

Read More 'ZTS' Stories Here

ZTS Price Returns

1-mo 5.25%
3-mo -7.66%
6-mo -28.93%
1-year -6.20%
3-year 57.15%
5-year 186.41%
YTD -28.21%
2021 48.26%
2020 25.76%
2019 55.71%
2018 19.45%
2017 35.55%

ZTS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ZTS Dividend History

Continue Researching ZTS

Here are a few links from around the web to help you further your research on Zoetis Inc's stock as an investment opportunity:

Zoetis Inc (ZTS) Stock Price | Nasdaq
Zoetis Inc (ZTS) Stock Quote, History and News - Yahoo Finance
Zoetis Inc (ZTS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4698 seconds.